Orient Europharma Co Ltd (4120) — Financial Flexibility Index
Orient Europharma Co Ltd (4120) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of NT$-110.17 Million (operating CF NT$-157.84 Million minus capex NT$47.67 Million) represents 0% of total liabilities (NT$4.54 Billion). Also explore Orient Europharma Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Orient Europharma Co Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Orient Europharma Co Ltd across 10 annual periods. Check strategic asset allocation of Orient Europharma Co Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Orient Europharma Co Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for Orient Europharma Co Ltd. For the full company profile including market capitalisation, see how much is Orient Europharma Co Ltd worth.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.00x | NT$-20.91 Million | NT$-121.11 Million | NT$5.75 Billion | ▼ -114.6% |
| 2023 | 0.02x | NT$165.37 Million | NT$64.67 Million | NT$6.65 Billion | ▼ -58.7% |
| 2022 | 0.06x | NT$420.41 Million | NT$-218.75 Million | NT$6.99 Billion | ▼ -78.2% |
| 2021 | 0.28x | NT$1.64 Billion | NT$77.65 Million | NT$5.95 Billion | ▲ +39.4% |
| 2020 | 0.20x | NT$841.33 Million | NT$608.55 Million | NT$4.25 Billion | ▲ +127.9% |
| 2019 | 0.09x | NT$352.35 Million | NT$227.37 Million | NT$4.06 Billion | ▼ -37.9% |
| 2018 | 0.14x | NT$432.92 Million | NT$231.31 Million | NT$3.10 Billion | ▼ -63.1% |
| 2017 | 0.38x | NT$968.75 Million | NT$601.08 Million | NT$2.56 Billion | ▲ +189.9% |
| 2016 | 0.13x | NT$336.05 Million | NT$111.24 Million | NT$2.57 Billion | ▼ -68.7% |
| 2015 | 0.42x | NT$873.51 Million | NT$643.97 Million | NT$2.09 Billion | — |